SEC Form 4 · accession 0001140361-15-000969
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter R Culpepper
Officer — CFO & COO
Period of report
Jan 7, 2015
Accepted (ET)
Jan 7, 2015 · 3:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2015 | M | 33,334 | $0.75 | A | 154,334 | I | 401(k) Plan |
| Common Stock | Jan 7, 2015 | M | 29,786 | $0.94 | A | 184,120 | I | 401(k) Plan |
| Common Stock | holding | — | — | — | 1,112,332 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.75 | Jan 7, 2015 | M | 33,334 | D | — | May 25, 2015 | Common Stock | 33,334 | 0 | D |
| Stock Option (right to buy)F2 | $0.94 | Jan 7, 2015 | M | 29,786 | D | — | Dec 9, 2015 | Common Stock | 29,786 | 145,214 | D |
Explanation of responses
- F1The option became exercisable in three equal annual installments beginning on May 26, 2006.
- F2The option became exercisable in three equal annual installments beginning on December 9, 2006.